+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Insulin Drugs Market by Product Type (Nph Human Insulin, Premixed Human Insulin, Regular Human Insulin), Administration Route (Cartridge, Prefilled Pen, Vial and Syringe), Distribution Channel, End User, Dosage Strength - Global Forecast 2025-2030- Product Image
Human Insulin Drugs Market by Product Type (Nph Human Insulin, Premixed Human Insulin, Regular Human Insulin), Administration Route (Cartridge, Prefilled Pen, Vial and Syringe), Distribution Channel, End User, Dosage Strength - Global Forecast 2025-2030- Product Image
Sale

Human Insulin Drugs Market by Product Type (Nph Human Insulin, Premixed Human Insulin, Regular Human Insulin), Administration Route (Cartridge, Prefilled Pen, Vial and Syringe), Distribution Channel, End User, Dosage Strength - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666172
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Human Insulin Drugs Market is rapidly transforming, shaped by scientific progress, regulatory shifts, and an evolving care delivery landscape. Senior decision-makers face heightened complexity as insulin therapies become more integrated with digital health and regional market dynamics shift.

Market Snapshot: Human Insulin Drugs Market Growth

The Human Insulin Drugs Market grew from USD 62.02 billion in 2024 to USD 67.79 billion in 2025. It is expected to continue growing at a CAGR of 8.87%, reaching USD 103.32 billion by 2030. This trajectory underscores substantial expansion potential, driven by the increasing prevalence of diabetes, technological advancements in insulin formulations, the rise of biosimilars, and changing reimbursement structures across major regions.

Scope & Segmentation

  • Product Types: Nph Human Insulin, Premixed Human Insulin (50/50 Mix, 70/30 Mix, 75/25 Mix), Regular Human Insulin
  • Administration Routes: Cartridge, Prefilled Pen (Disposable Pen, Reusable Pen), Vial And Syringe
  • Distribution Channels: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • End Users: Clinics, Home Care, Hospitals
  • Dosage Strengths: U100, U500
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Novo Nordisk A/S, Sanofi S.A., Eli Lilly and Company, Biocon Limited, Wockhardt Limited, Dr. Reddy's Laboratories Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Sun Pharmaceutical Industries Limited, Tonghua Dongbao Pharmaceutical Co., Ltd.

Key Takeaways for Senior Decision-Makers

  • Global insulin adoption patterns are shifting as biosimilars gain regulatory momentum and wider payer acceptance in core therapeutic areas.
  • Stakeholders are prioritizing digital integration, with smart pen technologies and connected devices redefining provider, patient, and payer relationships.
  • Manufacturers are diversifying their supply chain strategies to improve resilience and maintain competitive standing as procurement dynamics evolve by region.
  • Highly varied segmentation by product type, dosage, and administration reflects unique prescriber and patient preferences, impacting commercial priorities and innovation pipelines.
  • Strategic collaborations between multinational pharma companies and regional manufacturers are accelerating market entry and access goals in emerging territories.
  • Data-driven personalization and patient engagement tools are projected to drive incremental gains in adherence and health outcomes across target populations.

Tariff Impact on Distribution & Market Access

Newly enacted United States tariff measures are altering insulin drug distribution costs, affecting the sourcing of active pharmaceutical ingredients and finished formulations. In response, companies are localizing manufacturing, reengineering procurement models, and exploring risk-sharing contracts to address increased operational and logistics expenses. Value-based agreements and vertical integration trends are strengthening supply chain resilience while adaptive sourcing in regional hubs seeks to offset cost volatility. Patient advocacy and policy initiatives aim to protect at-risk groups from price shifts and to ensure continued access.

Methodology & Data Sources

The research employs a blend of peer-reviewed literature review, expert stakeholder interviews, and public domain quantitative analysis. Cross-functional peer review cycles, secondary source validation, and real-world data integration ensure all findings reflect current human insulin market realities and stakeholder priorities.

Why This Report Matters

  • Enables leaders to benchmark strategic decisions within a dynamic therapeutic and regulatory environment, ensuring actionable insight on market entry, pricing, and commercialization models.
  • Facilitates identification of technology, patient, and channel opportunities through region-specific, segmented intelligence on products, platforms, and access trends.
  • Supports resilient planning by mapping evolving tariff impacts, supply chain risks, and future real-world evidence requirements in human insulin development.

Conclusion

This report offers executive-ready, evidence-based analysis for navigating the changing human insulin marketplace. Decision-makers are empowered to formulate resilient growth strategies, drive innovation, and optimize access for diabetes management worldwide.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in biosimilar human insulin approvals driving market competition and price revisions
5.2. Expansion of government subsidy programs improving patient access to human insulin therapies in developing nations
5.3. Integration of digital insulin dosing platforms with traditional human insulin regimens enhancing treatment adherence
5.4. Strategic partnerships between biopharma firms and logistics providers optimizing global cold chain distribution of human insulin
5.5. Growing investment in next-generation basal human insulin analogues to reduce hypoglycemia risk and dosing frequency
5.6. Impact of patent expirations on brand-name human insulin sales and subsequent shift towards lower-cost alternatives
5.7. Increased emphasis on patient-centric support services within human insulin care pathways to improve outcomes
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Insulin Drugs Market, by Product Type
8.1. Introduction
8.2. Nph Human Insulin
8.3. Premixed Human Insulin
8.3.1. 50/50 Mix
8.3.2. 70/30 Mix
8.3.3. 75/25 Mix
8.4. Regular Human Insulin
9. Human Insulin Drugs Market, by Administration Route
9.1. Introduction
9.2. Cartridge
9.3. Prefilled Pen
9.3.1. Disposable Pen
9.3.2. Reusable Pen
9.4. Vial And Syringe
10. Human Insulin Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Human Insulin Drugs Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Human Insulin Drugs Market, by Dosage Strength
12.1. Introduction
12.2. U100
12.3. U500
13. Americas Human Insulin Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Human Insulin Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Human Insulin Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novo Nordisk A/S
16.3.2. Sanofi S.A.
16.3.3. Eli Lilly and Company
16.3.4. Biocon Limited
16.3.5. Wockhardt Limited
16.3.6. Dr. Reddy's Laboratories Limited
16.3.7. Torrent Pharmaceuticals Limited
16.3.8. Lupin Limited
16.3.9. Sun Pharmaceutical Industries Limited
16.3.10. Tonghua Dongbao Pharmaceutical Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HUMAN INSULIN DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HUMAN INSULIN DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HUMAN INSULIN DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HUMAN INSULIN DRUGS MARKET: RESEARCHAI
FIGURE 26. HUMAN INSULIN DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. HUMAN INSULIN DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. HUMAN INSULIN DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN INSULIN DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY NPH HUMAN INSULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY NPH HUMAN INSULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY 50/50 MIX, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY 50/50 MIX, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY 70/30 MIX, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY 70/30 MIX, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY 75/25 MIX, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY 75/25 MIX, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY REGULAR HUMAN INSULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY REGULAR HUMAN INSULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY CARTRIDGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY CARTRIDGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY DISPOSABLE PEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY DISPOSABLE PEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY REUSABLE PEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY REUSABLE PEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY VIAL AND SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY VIAL AND SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY U100, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY U100, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY U500, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY U500, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 93. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 96. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 97. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 98. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 99. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 100. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 101. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 106. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 107. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 110. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 111. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 112. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 113. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 114. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 115. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 120. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 179. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 182. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 183. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 184. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 185. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 186. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 187. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 192. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 193. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 196. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 197. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 198. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 199. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 200. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 201. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 206. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 221. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 224. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 225. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 226. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 227. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 228. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 229. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 234. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 235. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 238. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 239. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 240. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 241. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 242. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 243. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 248. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 291. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 294. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 295. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 296. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 297. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 298. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 299. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 304. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 319. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2018-2024 (USD MILLION)
TABLE 322. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY PREMIXED HUMAN INSULIN, 2025-2030 (USD MILLION)
TABLE 323. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 324. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 325. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2018-2024 (USD MILLION)
TABLE 326. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY PREFILLED PEN, 2025-2030 (USD MILLION)
TABLE 327. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 332. QATAR HUMAN INSULIN DRUGS MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human Insulin Drugs market report include:
  • Novo Nordisk A/S
  • Sanofi S.A.
  • Eli Lilly and Company
  • Biocon Limited
  • Wockhardt Limited
  • Dr. Reddy's Laboratories Limited
  • Torrent Pharmaceuticals Limited
  • Lupin Limited
  • Sun Pharmaceutical Industries Limited
  • Tonghua Dongbao Pharmaceutical Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 67.79 Billion
Forecasted Market Value ( USD ) by 2030 $ 103.32 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Human Insulin Market 2025-2033 - Product Image

Human Insulin Market 2025-2033

  • Report
  • 145 Pages
  • Global
From
Human Recombinant Insulin - Global Strategic Business Report - Product Image

Human Recombinant Insulin - Global Strategic Business Report

  • Report
  • 189 Pages
  • Global
From
Diabetes Injection Pens Market by Technology (Conventional Pens, Smart Pens), User Type (Type 1 Diabetic Patients, Type 2 Diabetic Patients), Insulin Type, Product Type, Distribution Channel, End User, Therapy Type - Global Forecast 2025-2030 - Product Image

Diabetes Injection Pens Market by Technology (Conventional Pens, Smart Pens), User Type (Type 1 Diabetic Patients, Type 2 Diabetic Patients), Insulin Type, Product Type, Distribution Channel, End User, Therapy Type - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Antidiabetic Drugs Market by Drug Class (Insulin, Oral Agents), Patient Type (Gestational Diabetes, Prediabetes, Type 1 Diabetes), Route Of Administration, Therapy Type, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Antidiabetic Drugs Market by Drug Class (Insulin, Oral Agents), Patient Type (Gestational Diabetes, Prediabetes, Type 1 Diabetes), Route Of Administration, Therapy Type, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Humulin (Recombinant Human Insulin) Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Humulin (Recombinant Human Insulin) Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From

About the Market

The Human Insulin market is a segment of the Endocrine and Metabolic Disorders Drugs market. It is composed of drugs used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use the insulin it produces. Human Insulin is a synthetic form of insulin, which is produced in a laboratory and is identical to the insulin produced by the human body. It is used to treat both type 1 and type 2 diabetes. Human Insulin is available in a variety of forms, including short-acting, intermediate-acting, and long-acting. It is typically administered via injection or an insulin pump. Some companies in the Human Insulin market include Novo Nordisk, Sanofi, Eli Lilly, and Biocon. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.